105 related articles for article (PubMed ID: 3111982)
1. Acquisition of cell-mediated immunity to Leishmania. I. Primary T-cell activation detected by IL-2 receptor expression.
Kaye PM
Immunology; 1987 Jul; 61(3):345-9. PubMed ID: 3111982
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin.
Reiner NE; Finke JH
J Immunol; 1983 Sep; 131(3):1487-91. PubMed ID: 6224858
[TBL] [Abstract][Full Text] [Related]
3. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
[TBL] [Abstract][Full Text] [Related]
4. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
Reiner NE
J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
6. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
7. Functional status of interleukin 2 receptors expressed by immature (Lyt-2-/L3T4-) thymocytes.
Lowenthal JW; Howe RC; Ceredig R; MacDonald HR
J Immunol; 1986 Oct; 137(8):2579-84. PubMed ID: 3093578
[TBL] [Abstract][Full Text] [Related]
8. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
Holaday B; Sadick MD; Pearson RD
J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649
[TBL] [Abstract][Full Text] [Related]
9. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
10. The murine IL 2 receptor. III. Cellular requirements for the induction of IL 2 receptor expression on T cell subpopulations.
Malek TR; Schmidt JA; Shevach EM
J Immunol; 1985 Apr; 134(4):2405-13. PubMed ID: 3919092
[TBL] [Abstract][Full Text] [Related]
11. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
[TBL] [Abstract][Full Text] [Related]
12. Activation of virus specific CTL clones: antigen-dependent regulation of interleukin 2 receptor expression.
Andrew ME; Churilla AM; Malek TR; Braciale VL; Braciale TJ
J Immunol; 1985 Feb; 134(2):920-5. PubMed ID: 3917480
[TBL] [Abstract][Full Text] [Related]
13. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection.
Melby PC; Tabares A; Restrepo BI; Cardona AE; McGuff HS; Teale JM
Exp Parasitol; 2001 Sep; 99(1):17-25. PubMed ID: 11708830
[TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
Melby PC; Yang J; Zhao W; Perez LE; Cheng J
Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
[TBL] [Abstract][Full Text] [Related]
15. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
[TBL] [Abstract][Full Text] [Related]
16. Recognition of Leishmania donovani antigens by murine T lymphocyte lines and clones. Species cross-reactivity, functional correlates of cell-mediated immunity, and antigen characterization.
Sheppard HW; Scott PA; Dwyer DM
J Immunol; 1983 Sep; 131(3):1496-503. PubMed ID: 6193191
[TBL] [Abstract][Full Text] [Related]
17. Proliferation of T lymphocytes in response to interleukin 2 varies with their state of activation.
Ashwell JD; Robb RJ; Malek TR
J Immunol; 1986 Oct; 137(8):2572-8. PubMed ID: 3093577
[TBL] [Abstract][Full Text] [Related]
18. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
[TBL] [Abstract][Full Text] [Related]
19. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses.
Malek TR; Robb RJ; Shevach EM
J Immunol; 1983 Feb; 130(2):747-55. PubMed ID: 6184403
[TBL] [Abstract][Full Text] [Related]
20. Developmentally controlled expression of IL 2 receptors and of sensitivity to IL 2 in a subset of embryonic thymocytes.
Hardt C; Diamantstein T; Wagner H
J Immunol; 1985 Jun; 134(6):3891-4. PubMed ID: 3921613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
